Toxic Chemical Waste Handling SOP for QC Labs
Contents
- 1. Purpose and scope
- 2. Responsibilities and related procedures
- 3. Risk review before handling waste
- 4. Example in-house process framework
- 5. Spill or abnormal event
- 6. Records and retention
- Frequently asked questions
- Can this SOP be used to neutralize bromine solution?
- Can cyanogen bromide waste be mixed with bleach and then poured down the drain?
- What PPE should an analyst wear?
- How long should batch-related GMP records be retained?
- References
In short: This illustrative SOP sets out a review and documentation framework for laboratory chemical waste. The example refers to bromine and cyanogen bromide solutions but gives no neutralisation or drain-disposal method; use the safety data sheet, local hazardous-waste rules and your site’s approved procedure.
1. Purpose and scope
Use this example to organize chemical-waste identification, segregation, temporary control, approved treatment or collection, and records in a QC laboratory. This example refers to bromine solution and cyanogen bromide solution used in a chlorpheniramine maleate test. Confirm the actual reagent names, concentrations, mixtures and current use from controlled methods and current safety data sheets (SDSs) before preparing a local SOP.
The WHO Laboratory Biosafety Manual, fourth edition, includes risk assessment and decontamination/waste-management monographs. Its waste-management guidance describes considering waste type and volume, chemical presence, segregation, packaging, labelling, transport and the available treatment methods; this is a framework for assessment, not approval of a specific chemical neutralization or drain-disposal method.
2. Responsibilities and related procedures
- Laboratory personnel: identify waste at the point it is generated, follow the approved handling and segregation procedure, and report an unknown stream, spill or container issue.
- Laboratory supervisor: confirm the waste stream and local procedure are approved, ensure users are trained, and arrange the approved collection or treatment route.
- Environmental health and safety (EHS) or the designated safety lead: review the chemical hazard assessment, container compatibility, treatment proposal and local disposal route.
- Quality assurance: manage controlled-document approval and associated records under the site’s quality system.
These are example role assignments; adapt them to local responsibilities.
See also:
- SOP for handling laboratory reagents
- General safety rules for the quality control laboratory
- SOP for cleaning the quality control laboratory
3. Risk review before handling waste
- Identify the chemical(s), source method, approximate amount, concentration and any known contaminants. If composition is unknown, keep the material under the site’s unknown-waste process and ask the designated safety lead for direction.
- Review the current SDS and the laboratory’s chemical risk assessment. Determine the required engineering controls, task-specific PPE, spill response, compatible container and temporary storage conditions.
- Keep incompatible or unidentified waste streams separate according to the approved compatibility assessment. Use a closable container suitable for the specific waste, clearly mark its contents and hazards, and place it in the storage arrangement approved by EHS.
- Do not improvise a chemical treatment, mix waste streams, dilute a waste stream, or discharge it to a sink based on this generic template. Use only a site-approved treatment method or collection route that has been reviewed for the actual contents and applicable local conditions.
The example PPE list names surgical gloves, a nose mask, safety goggles and an apron but does not identify chemical-specific glove material, eye/face protection, respiratory protection or exposure controls. Select controls from the current SDS and documented task risk assessment; do not treat this list as a complete PPE specification.
4. Example in-house process framework
Example in-house criterion (not a pharmacopoeial requirement): before collection or treatment, require a documented waste-stream assessment that identifies the contents, approved container, label, temporary storage location, responsible person and final route.
- Assign a trained person to prepare or close the container under the controls in the approved risk assessment.
- Use the container and label specified by the approved procedure. Include the contents or waste-stream identifier, hazards, date and responsible group as required locally. Keep the container closed except while adding waste and do not mix waste streams unless a validated local method explicitly permits it.
- If the site has approved onsite treatment, follow its current validated method exactly. This article provides no chemical neutralization recipe for bromine or cyanogen bromide waste.
- Otherwise, arrange collection by the site’s approved waste contractor or designated facility. Use the packaging, labelling, records and handover information specified by the current approved route.
- Record the waste-stream identity, amount or container count, date, preparer, storage location, treatment or transfer details, reviewer and related exception or receipt record.
5. Spill or abnormal event
If a container leaks, its contents are uncertain, or a person may have been exposed, stop routine handling and follow the site’s chemical-spill and emergency-response plan. Contact the local emergency or EHS lead listed in that plan. Do not attempt neutralization or cleanup using this template.
6. Records and retention
Maintain the approved waste assessment, treatment or collection records, training record, incident record and any contractor handover or receipt details required by the local procedure. Retain GMP records associated with a product batch for at least 1 year after the expiry date of that respective batch. Under EU GMP Part I Chapter 4 §4.11, batch documentation is kept for 1 year after expiry or 5 years after Qualified Person certification, whichever is longer; retain longer when local law or the marketing authorisation requires it. 21 CFR 211.180(a) sets at least 1 year after expiry for covered production, control or distribution records specifically associated with a drug-product batch.
Frequently asked questions
Can this SOP be used to neutralize bromine solution?
No neutralization method is established here. Use the current SDS, a documented compatibility assessment and the site’s EHS-approved treatment or collection route.
Can cyanogen bromide waste be mixed with bleach and then poured down the drain?
This example does not give a method for treating or disposing of this waste, and it does not authorise drain disposal. Use the safety data sheet, local hazardous-waste rules and the site’s approved procedure.
What PPE should an analyst wear?
Use the PPE and controls identified by the current SDS and task risk assessment. The example PPE list is incomplete for a chemical-specific assessment.
How long should batch-related GMP records be retained?
At least 1 year after the respective product batch expires. If EU GMP applies, keep batch documentation for 1 year after expiry or 5 years after Qualified Person certification, whichever is longer; retain longer where local law or the marketing authorisation requires it.
References
- World Health Organization. Laboratory Biosafety Manual, 4th edition, “Decontamination and waste management,” 2020, ISBN 978-92-4-001135-9. Official WHO monograph page. WHO PDF.
- World Health Organization. Laboratory Biosafety Manual, 4th edition, “Risk Assessment,” 2020, ISBN 978-92-4-001131-1. Official WHO monograph page.
- World Health Organization. Laboratory Biosafety Manual, 4th edition, “Personal protective equipment,” 2020, ISBN 978-92-4-001141-0. Official WHO monograph page.
- European Commission. EudraLex Volume 4, Part I, Chapter 4, “Documentation,” §4.11, January 2011. Official Chapter 4 PDF.
- United States Government. 21 CFR §211.180(a), “General requirements,” current eCFR text accessed 19 October 2026. eCFR.
Related articles
Analytical Method Validation: ICH Q2(R2) Guide for QC Labs
Analytical method validation under ICH Q2(R2) explained: validation vs verification vs transfer, Table 1 by test type, a protocol outline, a worked example and FAQs.
HPLC Interview Questions and Answers for Pharma QC
HPLC interview questions and answers for pharma QC freshers and analysts: principle, columns, mobile phase, system suitability, detectors, validation and troubleshooting.
OOS vs OOT in Pharma: Difference with Examples
Difference between OOS and OOT results in pharma QC: definitions, a comparison table, three worked examples, detection methods, investigation flow and interview Q&A.
QA vs QC in Pharma: Difference, Roles and Which to Choose
QA vs QC in pharma explained for freshers: definitions, a side-by-side table, a day in each role, skills, career moves and how to choose between them.